Covidien Sales LLC

Covidien Sales LLC, a foreign-owned for-profit subsidiary of Medtronic Inc., supplies specialized medical devices, equipment, and maintenance services to federal healthcare agencies as a prime contractor (88% of recent awards) and through subcontracts with distributors like Cardinal Health 200, LLC. The company competes in full-and-open federal procurement without set-aside designations, positioning itself as a large, multinational medical technology supplier across civilian health systems.

Covidien's federal portfolio centers on advanced surgical and diagnostic equipment: electrosurgical units (Valleylab FT10 generators, LigaSure platforms), ventilators (Puritan Bennett 980 systems, Medtronic PB980), gastrointestinal diagnostic systems (ManoScan catheters, EndoFLIP, PillCam capsule endoscopy), bronchoscopy and navigation equipment (Illumisite systems, Super Dimension planning stations), and related preventative maintenance and service agreements. Representative prime awards include a $913.5 million purchase order from Veterans Integrated Service Network 8 for Medtronic Situate Detection System X sponge detection equipment with five-year maintenance across nine Florida VA facilities; a $1.3 million definitive contract from US Pacific Fleet Forces to maintain Puritan Bennett 980 ventilators aboard the USNS MERCY and USNS COMFORT hospital ships through September 2029; a $268.3 million purchase order from VISN 10 for PillCam integration with Oracle Health and Cerner EHR systems; and a $5.87 million single-award indefinite delivery contract with VA Headquarters for electrosurgical units and accessories running through April 2029. On the sub side, Covidien performs medical/surgical equipment and supplies work under Cardinal Health 200, LLC across multiple fiscal years, and provides imaging and photoacoustic device components to Johns Hopkins University on a Phase 1 NIH proof-of-concept subaward.

Customer concentration is acute. VA customers dominate by both count and dollars — the top five agencies by award count (Indian Health Service 193 awards, Defense Logistics Agency Troop Support Medical 114 awards, VISN 10 with 113 awards, VISN 22 with 94 awards, and VISN 12 with 45 awards) account for 35% of all awards. By potential value, the picture shifts sharply: VISN 12 anchors $1.65 billion in combined potential value across just 45 awards — nearly 54% of Covidien's entire federal footprint — while DLA Troop Support Medical carries $900.1 million across 114 awards. Defense Health Agency places 74 awards worth $17 million. Thirteen other VISNs collectively drive lower-dollar transactional volume, signaling that Covidien's revenue concentration rests on a small number of high-value, multi-year maintenance and supply agreements.

Covidien holds primary positions on the GSA Medical Equipment and Supplies Schedule (FSS-65-II-A), from which 773 task orders carry $255.8 million in combined potential value. The company also sits on multiple VA Indefinite Delivery Contracts, including the $5.87 million electrosurgical-units IDC (May 2024 through April 2029), a $648 thousand GI Genius service-agreement IDC with VA Strategic Acquisition Center Frederick (June 2024 through June 2027), and a single-award Illumisite Navigation System IDC with VISN 6 (May 2026 through May 2031, $219.7 thousand). Two Defense Logistics Agency multiple-award contracts (SPE2DM20D9001 and SPE2DM20D2004) carry 38 and 36 task orders respectively, though dollar values are not disclosed in the source.

Activity has tracked flat to declining year over year: 99 awards in 2022, peaking at 130 in 2024, then dropping to 95 in 2025 and 54 in the first ten months of 2026. Over the next twenty-four months, 44 awards (combined potential value $5.2 million) reach ultimate completion, presenting recompete exposure; however, this figure represents only 1.4% of Covidien's $3.05 billion combined footprint, and the bulk of the company's value sits in longer-duration IDCs running through 2029–2031.

The portfolio splits 88% prime and 12% sub. Subcontract activity flows primarily through Cardinal Health 200, LLC as the named prime, with Covidien providing surgical staplers, sealers, dividers, patient monitoring sensors, electrosurgical equipment, and consumable supplies to federal medical/surgical distribution networks. Two small subawards through Leidos (June and July 2025) cover procurement of goods and services in support of a Statement of Work between March 2024 and March 2026.

Covidien's primary NAICS concentration sits in Surgical and Medical Instrument Manufacturing (1,210 awards) and Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (239 awards), with secondary exposure in Surgical Appliance and Supplies Manufacturing (168 awards) and equipment repair and maintenance categories (142 awards combined). Product Service Code 6814 (Medical and Surgical Instruments, Equipment, and Supplies) dominates at 1,340 awards; maintenance and repair services carry 149 awards.

Headquartered in Mansfield, Massachusetts, Covidien is a wholly owned subsidiary of Medtronic Inc., a foreign-owned, for-profit medical device manufacturer. The parent–child relationship is disclosed in the corporate structure block; the source does not identify separate operating divisions or subsidiary operating names under Covidien Sales LLC itself. The company's federal footprint reflects Medtronic's brand-name equipment dominance in VA and DoD healthcare infrastructure, with task orders flowing from end-user medical centers rather than through centralized procurement vehicles, creating a high-volume, lower-transaction-size profile punctuated by intermittent large maintenance contracts.